| Saponins as chemosensitizing substances that improve effectiveness and selectivity of anticancer drug—Minireview of in vitro studies P Koczurkiewicz, K Klaś, K Grabowska, K Piska, K Rogowska, ... Phytotherapy Research 33 (9), 2141-2151, 2019 | 25 | 2019 |
| Cinnamic acid derivatives as cardioprotective agents against oxidative and structural damage induced by doxorubicin P Koczurkiewicz-Adamczyk, K Klaś, A Gunia-Krzyżak, K Piska, ... International journal of molecular sciences 22 (12), 6217, 2021 | 13 | 2021 |
| How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials. gov N Hutchinson, K Klas, BG Carlisle, J Kimmelman, M Waligora Plos one 17 (1), e0262114, 2022 | 8 | 2022 |
| Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed G Nilsonne, S Wieschowski, NJ DeVito, M Salholz-Hillel, T Bruckner, ... medRxiv, 2024.02. 04.24301363, 2024 | 1 | 2024 |
| Bioethics of somatic gene therapy: what do we know so far? P Buedo, A Bianchini, K Klas, M Waligora Current Medical Research and Opinion 39 (10), 1355-1365, 2023 | 1 | 2023 |
| Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis N Hutchinson, K Klas, BG Carlisle, M Polak, J Kimmelman, M Waligora BMC Research Notes 15 (1), 368, 2022 | 1 | 2022 |
| Masking M Waligora, K Klas The SAGE Encyclopedia of Research Design 1, 860-861, 2022 | 1 | 2022 |
| Synthesis, in Silico and in Vitro Study on Phase I Metabolism of the Potent 5-Ht7/5-Ht1a/D2 Receptor Ligand: 4-Fluoro n-(1-{2-[2-(Methylsulfanyl)-Phenoxy] Ethyl} Pyrrolidin-3 … P Kubowicz-Kwaśny, K Piska, K Klaś, P Żmudzki, V Canale, P Zajdel, ... Pharmaceutical Chemistry Journal 53 (8), 713-719, 2019 | 1 | 2019 |
| Similar Safety Profile of the Enantiomeric N-Aminoalkyl Derivatives of Trans-2-Aminocyclohexan-1-ol Demonstrating Anticonvulsant Activity K Słoczyńska, P Koczurkiewicz, K Piska, B Powroźnik, K Wójcik-Pszczoła, ... Molecules 24 (13), 2505, 2019 | 1 | 2019 |
| The informativeness of trials in COVID-19: Lessons learned from the Coronavirus pandemic N Hutchinson, B Carlisle, K Klas, M Polak, J Kimmelman, M Waligora | 1 | |
| Ethical challenges of clinical trials with a repurposed drug in outbreaks K Klas, K Strzebonska, M Waligora Medicine, Health Care and Philosophy 26 (2), 233-241, 2023 | | 2023 |
| Saponin Fraction CIL1 from Lysimachia ciliata L. Enhances the Effect of a Targeted Toxin on Cancer Cells P Koczurkiewicz-Adamczyk, K Grabowska, E Karnas, K Piska, D Wnuk, ... Pharmaceutics 15 (5), 1350, 2023 | | 2023 |
| REMEDY. Research Ethics in Medicine Study Group M Waligora, M Polak, P Buedo, M Wasylewski, K Strzebonska, K Klaś, ... SAGE, 2022 | | 2022 |
| Badanie właściwości kardioprotekcyjnych pochodnych kwasu cynamonowego w modelu kardiomiocytów różnicowanych z ludzkich indukowanych pluripotencjalnych komórek macierzystych K Klaś | | 2019 |
| Zastosowanie modeli in vitro w przedklinicznych badaniach bezpieczeństwa nowych kandydatów na leki K Klaś, P Guzy, K Piska, K Wójcik-Pszczoła, P Koczurkiewicz-Adamczyk, ... Farmacja Polska 74 (1), 2018 | | 2018 |
| Saponin Fraction CIL1 from Lysimachia ciliata L P Koczurkiewicz-Adamczyk, K Grabowska, E Karnas, K Piska, D Wnuk, ... Enhances the Effect of a Targeted Toxin on Cancer Cells. Pharmaceutics, 0 | | |
| Clinical trials in Poland: Reporting results on the European Union Clinical Trials Register K Strzebonska, K Klas, L Bandura-Morgan, NJ DeVito, M Polak | | |
